ZYUS Life Sciences has completed the previously announced acquisition of Kentucky-based healthcare technology company Revon Systems.
ZYUS, which is focused on the global development and commercialization of innovative and patient-focused cannabinoid-based therapeutics and product candidates, intends to utilize Revon’s proprietary artificial intelligence–enabled technology platform as a digital therapeutic patient interface and a real-time data collection platform during various future planned clinical studies and trials.
“We welcome the Revon team onboard at ZYUS and are excited to utilize the proprietary technology platform in future planned clinical trials of our pain treatment–related product candidates,” said Brent Zettl, President and CEO of ZYUS. “By generating a stronger interface and engagement with patients, we aim to help expedite the clinical trial process as we pursue innovative therapies to better the lives of patients.”
ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates. Through clinical research and IP development, we intend on delivering high-quality oils, gel-caps, topical creams and other cannabinoid-based therapeutics and product candidates to patients worldwide.
At ZYUS, our vision is to elevate cannabinoids as a standard of care and to expand the potential of medicine—in pursuit of a transformational impact on patients’ lives. ZYUS: Advancing the Science of Well-Being.
Revon is a Kentucky-based healthcare technology company that has developed a data collection platform that integrates mobile technology and connected devices with health care services and therapies.
The platform’s digital interface supports data collection for the investigation of the performance of pharmaceutical and other interventions in various patient populations. Revon’s technology platform enables smart registry services, real world evidence collection and patient reported outcomes tracking for pharmaceutical and medical device companies conducting clinical trials. – NS Medical Devices